2nd Dose at Sarah Cannon Research - Advanced Prostate...

Advanced Prostate Cancer

21,056 members26,262 posts

2nd Dose at Sarah Cannon Research

Pmann profile image
10 Replies

Morning folks,

Finishing second dose of XmAb808

and all is well so far.

Blood work looks good and have to wait four hours post dose.

On Cipro for UTI and that is better too

Let’s kill those cancer cells

Written by
Pmann profile image
Pmann
To view profiles and participate in discussions please or .
Read more about...
10 Replies
KocoPr profile image
KocoPr

excellent!

cancer.gov/publications/dic...

anti-B7-H3/CD28 bispecific antibody XmAb808

A bispecific antibody directed against the tumor-associated antigen (TAA) and immunoregulatory protein B7-homologue 3 (B7-H3, CD276) and the co-stimulatory T-cell surface glycoprotein CD28, with potential immunostimulating and antineoplastic activities. Upon administration of anti-B7-H3/CD28 bispecific antibody XmAb808, this bispecific antibody binds to both B7-H3 on certain tumor cells and CD28 on cytotoxic T-lymphocytes (CTLs). This activates and redirects CTLs to B7-H3-expressing tumor cells, which may result in the CTL-mediated cell death of B7-H3-expressing tumor cells. B7-H3, a type I transmembrane protein and a member of the B7 co-stimulatory protein superfamily, is overexpressed on certain tumor cell types and on various immune cells. It is a negative regulator of the T-cell activation and its overexpression plays a key role in tumor cell invasion and metastasis.

Pmann profile image
Pmann in reply to KocoPr

Thank you for the kind words.

That is the trial.

I am still on Eliguard.

I did have gene testing and it did show one wacko gene.

Cannot locate it right now under massive pile of medical records.

I did not show link to prostate directly but to ovarian cancer and a child blood disorder.

KocoPr profile image
KocoPr in reply to Pmann

On your wacko gene if it was awhile ago i would search to see if any new info came out on it. They are constantly adding more genes to the PCa list.

I always research my gene mutations looking for new research and possible treatments.

Pmann profile image
Pmann in reply to KocoPr

The genomic testing was last October, and it was discussed with Dr. at SCRI as an option but this trial seemed better and a slot came open so this is my path. Thanks for the input.

KocoPr profile image
KocoPr in reply to Pmann

It’s a good path!

KocoPr profile image
KocoPr

is this the trial?

cancer.gov/research/partici...

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Exclusion Criteria

Subjects currently receiving other anticancer therapies

Do they mean you are not on any ADT?

KocoPr profile image
KocoPr

wow! Reading your bio you road that treatment train for 24 years! Your a true survivor and warrior.

Out of curiosity did you ever get genetic testing? Germline, somatic, liquid biopsy?

85236442968 profile image
85236442968

Pmann

What a journey you have been on.

You must be the Alpha Warrior on this site.

Best of luck on the trial and your future.

I am the same age as you.

j-o-h-n profile image
j-o-h-n

At 25 years you get a gold watch.......keep up the good work.....

Good Luck, Good Health and Good Humor.

j-o-h-n

j-o-h-n profile image
j-o-h-n

Sorry, make that plated.........

Good Luck, Good Health and Good Humor.

j-o-h-n

You may also like...

Lutetium treatment at Johns Hopkins - 2nd dose

I had my second dosing of the lutetium. I was identified as being “avid’ and therefore a good...

Half Dose Abiraterone

anybody on here half dose abiraterone and if so, is it as successful as full dose? Thanks!

Abiraterone, standard or low dose.

take low dose abiraterone (250 mg and 300 calorie breakfast) and how many take the standard dose....

How is radiation dose determined?

wide variance in radiation dose length and total dose. How is the best dose determined? How does...

Low Dose Chemotherapy

Has anybody done low dose chemotherapy for their prostate cancer? Some encouraging studies analysed